Möchten Sie immer auf dem neuesten Stand bleiben?

PORTOLA VALLEY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, the leading nonprofit funder of Lyme disease research in the US, today announced results from two independent...

60 Degrees Pharma unveils “B-FREE” Phase 2 trial for chronic babesiosis, engaging patients in naming and supporting Lyme research groups.

Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval:...

SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Dr. Anita Gupta, a professor of medicine at UC Riverside, has been awarded the 2025 Arnold P. Gold Humanism in Medicine Award. This prestigious honor...

VANCOUVER, British Columbia, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today provided an update on the progress of the Quebrada Blanca...

Melville, NY, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Canon U.S.A., Inc. a leader in digital imaging solutions and a proud partner of the New York Yankees, recently celebrated its 22nd annual Canon...

New York, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Always consult a qualified healthcare professional before starting...

Select units of Cosentyx to be made available at 55% discount off list price on direct-to-patient (DTP) platform beginning November 1, 2025DTP offering to expand to other appropriate products;...

Chicago, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The global benign prostatic hyperplasia surgical treatment market was valued at US$ 10.5 billion in 2024 and is expected to reach us$ 16.5 billion by...

Ottawa, Sept. 23, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global behavioral health market is forecasted to expand from USD 127.20 billion in 2024 to USD 172.61 billion by 2034, growing...